Tci Wealth Advisors, Inc. Castle Biosciences Inc Transaction History

Tci Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$19.47 - $28.49 $3,193 - $4,672	164 New	164 $3,000
Q2 2022 Jul 19, 2022	SELL	$16.0 - $45.99 $2,736 - $7,864	-171 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$33.17 - $46.98 $862 - $1,221	26 Added 17.93%	171 $8,000
Q4 2021 Jan 24, 2022	BUY	$39.06 - $67.58 $2,617 - $4,527	67 Added 85.9%	145 $6,000
Q3 2021 Oct 29, 2021	SELL	$60.13 - $77.6 $1,382 - $1,784	-23 Reduced 22.77%	78 $5,000
Q2 2021 Aug 02, 2021	BUY	$50.07 - $76.78 $2,503 - $3,839	50 Added 98.04%	101 $7,000
Q1 2021 Apr 29, 2021	BUY	$58.92 - $97.33 $1,767 - $2,919	30 Added 142.86%	51 $3,000
Q4 2019 Jan 27, 2020	BUY	$15.74 - $35.04 $330 - $735	21 New	21 $1,000

210

26.6M

128K

35.4K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $677M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.